about
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic ratsInhibition of ocular aldose reductase by a new benzofuroxane derivative ameliorates rat endotoxic uveitis.Neuropathic pain: is the end of suffering starting in the gene therapy?Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.Stem cell therapy: the great promise in lung disease.Stem cell therapy for neuropathic pain treatment.Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophagesMesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.Possible use of Trichuris suis ova in autism spectrum disorders therapy.Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.Perspectives on the use of stem cells for autism treatmentMesenchymal stem cells in treating autism: Novel insights.Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat.Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II.The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia.Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin.Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice.Immunohistochemical detection with quantum dots.State-of-the-art on basic and applied stem cell therapy; Stem Cell Research Italy-International Society for Cellular Therapy Europe, Joint Meeting, Montesilvano (PE)-Italy, June 10-12, 2011.Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).The A1 adenosine receptor as a new player in microglia physiology.Stem cell therapy in autism: recent insightsThe galactosylation of Nω-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic miceRole of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic painApoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in ratA single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic miceStem Cell-Derived Exosomes in Autism Spectrum DisorderDe novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial ProteinsNew Frontiers in Stem Cell Research and Translational ApproachesSpeech-Stimulating Substances in Autism Spectrum DisordersAltered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic painAutism Spectrum Disorders: Potential Neuro-Psychopharmacotherapeutic Plant-Based DrugsHuman mesenchymal stem cells as novel neuropathic pain tool
P50
Q34540999-8DA7A40D-E770-4936-A44A-E75BEE2ED1C0Q34569761-B5CBD1C4-569F-425D-89E9-42FB33526E64Q36048035-D647296D-8447-4CBD-9390-9EEC4ED6BD92Q36150334-BE72C0F3-8D34-461C-B90B-46963AFB0C18Q37362617-B1D7A0F5-E95E-4CBE-9DA2-9BA20C2E503DQ37536064-85BF9AF4-3F9A-4B46-965C-CD67417B3498Q37542184-7DCBEA62-E589-4F4D-B2F5-5674E7F4B7CDQ37718217-4239E1C5-372D-4E1E-A467-A224F9399439Q37729144-DE91BC12-7D51-4AF7-A025-DCED01F4DC69Q38099973-89499BCD-0568-49AD-9708-A10F73B15A60Q38150889-BCC69258-11A5-4185-A7EC-3A50BF58A1E1Q38162181-2A13C906-0F20-4BBF-B921-5F26F73E5B96Q38207602-7EB503A1-6F84-42D7-ABAD-7A31A3DA8F0AQ38374569-46217D48-3C73-4BA8-A9C8-F187084D7B35Q39411024-BC410B30-FA48-4119-813A-95EA71259DB9Q41706699-1A2F0914-2C3D-4E9A-B15A-E23366F4F277Q43752191-8BD82DE3-D22F-4757-8FD3-505F57AE1D22Q44771359-991E6060-1580-4911-B347-3025E21195BDQ46212445-FBDA51E1-E268-4E38-B36A-C2560214A742Q46649601-ABF38C96-1EBD-46DC-AA0D-43BF2F6D1725Q46855576-34765A3B-4E4E-461E-934B-14751E5E1BF6Q47556874-BB0A901A-4E59-44EC-8C79-DE5A36F809D6Q48399250-B02F26C6-D85A-42A9-B0E3-58FBBED79A18Q51082540-723B8D48-478A-44BE-A396-131A9E541397Q51665964-DDE8C270-50EE-471C-9EA0-CAA155E493C5Q52594563-53728F31-22C6-48AB-AADF-DCFE9127BD58Q53081693-FD29A311-DB9C-4B54-9B02-782FFF7F0EA5Q58698694-E91700E2-0D24-4284-AC80-523DBB3B29BAQ60686094-DB5ECECA-BB4F-4010-83C8-C9F1857DBFA3Q60686099-B179BBA4-AB5C-4AF6-9788-2CE773835EC0Q77850688-AE5B9099-5C15-475D-AF21-A303238E7894Q83049841-A6DA6FC8-E939-4BF9-A904-2CF14D23CF29Q89597082-B4612EF6-6368-4C3A-ACAA-A6C0C7A64346Q91614876-B9A7A3B8-2041-46CF-B5B9-E56800F79372Q92704220-D1D08034-C903-476A-9CF4-F6BB60A68178Q92854992-4215F6B9-DEA8-4EDD-BBFB-D548E7321AD8Q92891349-CC1A00F4-6AA0-428A-B8F9-F8710729F37DQ93070439-3C586C80-425C-4EB6-A00D-9C8C12911830Q95576542-A9E88369-849E-4E96-B379-7B7154F18E21
P50
description
researcher ORCID: 0000-0002-3779-2596
@en
wetenschapper
@nl
name
Dario Siniscalco
@ast
Dario Siniscalco
@en
Dario Siniscalco
@es
Dario Siniscalco
@nl
type
label
Dario Siniscalco
@ast
Dario Siniscalco
@en
Dario Siniscalco
@es
Dario Siniscalco
@nl
prefLabel
Dario Siniscalco
@ast
Dario Siniscalco
@en
Dario Siniscalco
@es
Dario Siniscalco
@nl
P106
P1153
23019762400
P21
P31
P496
0000-0002-3779-2596